Stages

Signs Menopause is Ending

Creator: Dr Nadira Awal
Published: 2026-01-15

How to know your transition is complete and what to expect next.

By Dr Nadira AwalBMS Specialist3 min readMedically reviewed 9 July 2026

Ceramic vase with dried grass in soft window light

Many symptoms ease as your body adapts, but some — like vaginal dryness or bone loss — need ongoing attention. Learn what typically settles and what needs continued care.

'Ending' is not quite the right word — hormones don't return, and post-menopause is a permanent state, not a phase you emerge from. But many of the acute, disruptive symptoms of perimenopause and early post-menopause do settle over time, usually 4–7 years after the last period, with a smaller proportion of women (roughly 10%) continuing to experience vasomotor symptoms for a decade or more. Understanding what genuinely eases, what tends to persist, and what needs ongoing treatment helps you plan for the decades of good health that lie ahead. Post-menopause is not a decline — it is a distinct life stage where the priorities of the body shift from reproductive to cardiometabolic and skeletal, and where thoughtful medical care can add years of vigour, independence and mental sharpness.

What tends to settle over time

Hot flushes and night sweats often reduce in intensity and frequency after 4–7 years, though a significant minority still experience them into their 60s and beyond.
Mood swings and anxiety usually stabilise once oestrogen stops fluctuating wildly and reaches a steadier (albeit low) baseline.
Sleep tends to improve, particularly if night sweats fade — though insomnia may persist for other reasons.
Heavy or unpredictable bleeding stops permanently 12 months after the final period.
Cyclical symptoms (breast tenderness, PMS-style irritability) disappear once cycles stop entirely.
Migraine linked to hormonal fluctuation often improves once cycles cease, though menopausal migraine can persist and needs its own plan.

What often continues or worsens without treatment

Genitourinary syndrome of menopause (GSM) — vaginal dryness, painful sex, urinary urgency, recurrent UTIs — almost always worsens without local oestrogen.
Bone density loss continues silently for the rest of your life; osteoporosis is the biggest untreated risk of low oestrogen.
Skin thinning, hair changes, joint stiffness and dry eyes typically persist.
Cardiovascular risk keeps climbing — this is a lifelong shift, not a temporary phase.
Cognitive changes may stabilise but do not reverse without treatment.
Sarcopenia (loss of muscle mass) accelerates in the 50s and 60s and is a leading cause of frailty in later life.

A menopause specialist reviewing an older patient — HRT decisions in your 60s and beyond are individual — there is no arbitrary age cut-off.

The three long-term risks that matter most

Osteoporosis — 1 in 2 women over 50 will have a fragility fracture; a hip fracture at 75+ carries a 1-year mortality around 20%.
Cardiovascular disease — the leading cause of death in UK women; the risk pattern changes markedly after menopause.
Cognitive decline and dementia — women make up two-thirds of Alzheimer's cases; the early post-menopausal years appear to be a critical window for prevention.

Why continued HRT can still be right for many women

There is no arbitrary age cut-off — NICE and BMS both make this explicit.
The decision balances symptom relief and bone/cardiovascular benefit against individual risk, reviewed yearly.
Transdermal oestrogen (patches, gel, spray) has a particularly favourable long-term safety profile.
Local vaginal oestrogen is safe for indefinite use, even into your 70s and 80s.
Many women continue HRT into their 60s or beyond specifically for bone protection and quality of life.
Stopping HRT is not obligatory at any age; it is a shared decision reviewed regularly.

Life beyond acute symptoms — what to build

Strength training twice a week — the single most powerful intervention for musculoskeletal ageing.
Aerobic activity 150 minutes a week for cardiovascular and cognitive protection.
A Mediterranean-pattern diet with adequate protein (1.2–1.6 g/kg body weight).
Ongoing screening: mammograms, cervical screening as scheduled, bowel cancer screening from 50–74, blood pressure and cholesterol yearly.
Social connection, purposeful activity and cognitive stimulation — evidence for dementia prevention is now strong.

Signals to book a review

Any post-menopausal bleeding — needs urgent gynaecology review to exclude endometrial cancer, never ignore.
New or worsening urinary symptoms — often GSM, highly treatable.
Loss of height greater than 4cm, or a low-trauma fracture — think osteoporosis.
New palpitations, chest pain or breathlessness — cardiovascular disease presents differently in women.
Persistent low mood, brain fog or fatigue that is limiting your life.

Key takeaway

Menopause never really 'ends' — but the acute chaos of perimenopause almost always does. What replaces it is a new, lower-oestrogen normal that benefits from thoughtful, individualised care for decades to come. The women who thrive in their 60s, 70s and 80s are those who treat post-menopause as an active phase of prevention, not a passive one of decline.

How Dr Awal approaches this in clinic

Every consultation starts with your full story — symptoms, cycle, medical history, family history and what you've already tried. From there we look at whether hormonal treatment, non-hormonal options, lifestyle changes or a combination will give you the best result, and we tailor the plan to your age, risk factors and preferences.

A detailed 60 minute first appointment — no rushed 10-minute slots.
Evidence-based recommendations aligned with NICE NG23 and BMS guidance.
Body-identical HRT considered first-line where appropriate.
Shared-care letters sent to your NHS GP so treatment can continue affordably.
Follow-up at 3 months to fine-tune your regimen and address side effects.
Ongoing annual reviews so your plan evolves with you.

Common questions we hear about this

Do I need to be at a certain age to be seen?

No. We see women in early perimenopause (often late 30s and 40s), through post-menopause and beyond. Age alone doesn't decide whether treatment is right — symptoms, health history and goals do.

Will my GP continue the prescription?

In most cases yes. After your consultation we send a detailed shared-care letter with the diagnosis, treatment plan and rationale so your NHS GP can prescribe on the NHS. Not every practice accepts shared care — we'll discuss this in your appointment.

What if I've tried HRT before and it didn't suit me?

Very common — often the type, dose or route wasn't right rather than HRT itself. We review what you've tried, why it didn't work, and adjust accordingly. Many women who thought HRT wasn't for them do well on a different preparation.

How long will I need to stay on treatment?

There is no set upper time limit for HRT. Current BMS and NICE guidance supports continuing HRT for as long as the benefits outweigh the risks for you personally. We review this together every year so you stay in control of the decision.

Where do you see patients?

All consultations at Pause and Co Healthcare are conducted securely via video, allowing us to support patients anywhere in the UK. Prescriptions and shared care arrangements are managed in the same way, regardless of your location.

About the author

Dr Nadira Awal is a British Menopause Society Advanced Menopause Specialist with 15+ years' NHS and private experience. She holds the BMS Advanced Certificate in Menopause Care, sits on the BMS Programme Planning Group, and advises the UK Government Menopause Strategy Group. Read her full profile.

Sources & further reading

General information only — not a substitute for personalised medical advice. Always speak to your GP or a menopause specialist about your own situation.

Talk it through